Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

Ítems similars

• Adverse Effects of GLP-1 Receptor Agonists
  per: Filippatos, Theodosios D., et al.
  Publicat: (2014)
• US creates blame-free adverse event reporting
  per: Guthrie, Patricia
  Publicat: (2006)
• Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
  per: Wang, Tiansheng, et al.
  Publicat: (2019)
• Inquiry into adverse events in trial blames drug, not study design
  per: Mayor, Susan
  Publicat: (2006)
• Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
  per: Mosterd, Charlotte M., et al.
  Publicat: (2020)